---
title: "Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290603458.md"
description: "Atrium Therapeutics granted inducement equity awards to eight newly hired non-executive employees on June 20. The package includes 66,000 non-qualified stock options with an exercise price of $12.66 and 33,000 restricted stock units. Options vest 25% at year one then monthly over three years, while RSUs vest 25% at year one then annually over three years."
datetime: "2026-06-23T20:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290603458.md)
  - [en](https://longbridge.com/en/news/290603458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290603458.md)
generator: "portal-rs"
---

# Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66

-   Atrium Therapeutics granted inducement equity awards to eight newly hired non-executive employees on June 20. \* Package totals 66,000 non-qualified stock options, exercise price USD 12.66, with 25% vesting at year one then monthly over three years. \* Also issued 33,000 restricted stock units, with 25% vesting at year one then annually over three years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA90548) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [RNA.US](https://longbridge.com/en/quote/RNA.US.md)

## Related News & Research

- [Avidity Biosciences (NASDAQ:RNA) Issues Earnings Results](https://longbridge.com/en/news/295865390.md)
- [vTv Therapeutics grants 2,500 inducement stock options priced at $31.48 per share](https://longbridge.com/en/news/296394653.md)
- [Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price](https://longbridge.com/en/news/296264888.md)
- [Atrium Therapeutics awards new hire stock options for 11,000 shares at $13.48 each](https://longbridge.com/en/news/296541914.md)
- [Dyne Therapeutics grants new-hire equity awards for 212,500 shares under inducement plan](https://longbridge.com/en/news/296530830.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**